M&A Deal Summary

Eximia Acquires Tidewater Clinical Research

On August 2, 2024, Eximia acquired life science company Tidewater Clinical Research

Acquisition Highlights
  • This is Eximia’s 1st transaction in the Life Science sector.
  • This is Eximia’s 1st transaction in the United States.
  • This is Eximia’s 1st transaction in Virginia.

M&A Deal Summary

Date 2024-08-02
Target Tidewater Clinical Research
Sector Life Science
Buyer(s) Eximia
Deal Type Add-on Acquisition
Advisor(s) Viking Mergers & Acquisitions (Financial)

Target

Tidewater Clinical Research

Norfolk, Virginia, United States
Tidewater Clinical Research specializes in conducting clinical trials focused on women's health. Tidewater Clinical Research was founded in 1994 and is based in Norfolk, Virginia.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Eximia

Dover, Delaware, United States

Category Company
Sector Life Science
DESCRIPTION

Eximia is a multi-site, multi-therapeutic, clinical research site network serving pharmaceutical, biotech companies, and CROs and providing research services across a diverse range of therapeutic indications with access to underrepresented patient populations. Eximia is based in Dover, Delaware.


DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 2
State (Virginia) 1 of 1
Country (United States) 1 of 2
Year (2024) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-16 Integrated Clinical Trial Services

West Des Moines, Iowa, United States

Integrated Clinical Trial Services specializes in conducting clinical trials for pharmaceutical companies. Integrated Clinical Trial Services focuses on patient recruitment, retention, and compliance throughout the clinical trial process. Integrated Clinical Trial Services was founded in 2005 and is based in West Des Moines, Iowa.

Buy -